Myrtelle
Operator of a gene therapy company intended to offer innovative clinical trials for the treatment of the rare monogenetic disorder. The company helps to address an array of diseases with white matter ...
Valuation
$0
Share Price
N/A
Total Raised
$52M
Last Round
N/A